Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis

  • Technology appraisal guidance
  • TA988
  • Published: 
Final Draft Guidance issued for the appeal period.